Literature DB >> 25983174

OCT for bifurcation stenting: what have we learned?

Niels Ramsing Holm1, Tom Adriaenssens, Pascal Motreff, Toshiro Shinke, Jouke Dijkstra, Evald Høj Christiansen.   

Abstract

Treatment of bifurcation lesions by percutaneous coronary intervention (PCI) shows major variation in complexity. Intravascular optical coherence tomography (OCT) provides high-resolution images of the pathoanatomy, thrombus, wires and stent positions during the procedure. This information may prove crucial in optimising PCI results and clinical outcomes after complex bifurcation treatment. Mounting evidence confirms the feasibility of OCT in bifurcations, and specific steps where OCT may be advantageous in guiding bifurcation PCI have been identified. Awaiting major clinical outcome trials, OCT has already entered the European guidelines for myocardial revascularisation. This paper aims to provide an overview of the potential clinical use of OCT in bifurcations.

Entities:  

Mesh:

Year:  2015        PMID: 25983174     DOI: 10.4244/EIJV11SVA14

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  3 in total

Review 1.  A review in enormity of OCT and its enduring understanding of vulnerable plaque in coronary bifurcation lesion.

Authors:  Rajiv Shrestha; Aanchal Shrestha; Jing Kan; Shaoliang Chen
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-01       Impact factor: 2.357

2.  Prognostic significance of the Medina classification in bifurcation lesion percutaneous coronary intervention with second-generation drug-eluting stents.

Authors:  Leor Perl; Guy Witberg; Gabriel Greenberg; Hana Vaknin-Assa; Ran Kornowski; Abid Assali
Journal:  Heart Vessels       Date:  2019-09-17       Impact factor: 2.037

3.  Optical coherence tomography assessment of a complex bifurcation lesion treated with double kissing Crush technique: A case report.

Authors:  Jin-Zan Cai; Yao-Jun Zhang; Tian Xu; Yong-Xiang Zhu; Chen-Yu Mao; Christos V Bourantas; Tom Crake; Shao-Liang Chen
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.